Russell Hanson is currently Chief Scientific Officer of Endjinn a Consensys Spoke company. Consensys is the company behind Ethereum, the premier global blockchain enterprise software product. Prior to joining Consensys he was a professor of Genetics and Genomic Sciences at the Mount Sinai School of Medicine where his group worked in precision medicine and applications of artificial intelligence and deep learning to medical imaging. Applications of electronic medical records, medical imaging data, genetics, AI, and blockchain will likely lead to profound changes in medical treatments, medical innovation and understanding globally. In his spare time he likes to motorcycle and paraglide.